Borregaard ASA

Research Borregaard ASA (BO4) on Bullrun: valuation model: 18.2% overvalued, market cap EUR 1.27B, P/E 26.0, dividend yield 3.3%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerBO4
• ExchangeF
• CountryNorway
• SectorBasic Materials
• IndustrySpecialty Chemicals
• CurrencyEUR
• Valuation signal18.2% overvalued
• Market capEUR 1.27B
• P/E26.0
• Dividend yield3.3%
• Financial periodFY2024
• RevenueNOK 7.62B
• Revenue growth6.8%
• Net incomeNOK 829.00M

Valuation Snapshot

Bullrun's latest valuation model marks Borregaard ASA as 18.2% overvalued; latest market cap is EUR 1.27B; P/E is 26.0; dividend yield is 3.3%.

About Borregaard ASA

Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers and biovanillin derived from lignin for agrochemicals, batteries, industrial binders, and construction, as well as to flavor and fragrance companies, and food and beverage industry.

Frequently asked questions

Is Borregaard ASA overvalued or undervalued?

Bullrun's valuation model currently marks Borregaard ASA as 18.2% overvalued.

What is Borregaard ASA's market cap?

Borregaard ASA's market capitalization is EUR 1.27B.

What is Borregaard ASA's P/E ratio?

Borregaard ASA's price-to-earnings (P/E) ratio is 26.0.

Does Borregaard ASA pay a dividend?

Borregaard ASA has a dividend yield of 3.3%.

What does Borregaard ASA do?

Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals.